same tissue. From a public health perspective, the points discussed here as well as the absence of data on prevalent tumors, like breast and prostate cancer, do not support the oversimplified message conveyed by the media that the majority of cancer cases cannot be prevented.
jor role in determining the risk of D-tumors. In contrast, stochastic factors presumably attributable to errors deriving from DNA replication are implicated as primary determinants of R-tumor incidence. Given the fact that the majority of the tumors analyzed fall within the R group, the authors propose that random mutations generated during the process of DNA replication in normal and non-cancerous stem cells are responsible for two thirds of the tumors considered. On the basis of the data collected, the authors propose that 'bad luck' may be a significant factor in the incidence of certain types of tumors. The study provides a new hypothesis as to the basic mechanisms underlying the genesis of various types of cancers. Predominantly because of the serious ramifications within the context of cancer prevention, the article and the corresponding editorial [2] have been extensively covered by media and have spurred mixed reactions by the scientific community [3] . The present Second Opinion aims at highlighting some of the potential confounding factors associated with the analysis performed in the study, as these may apply to kidney cancer as well. In particular, it is in our scope to point out that the oversimplified message conveyed by the media that the 'the majority of cancer is due to bad luck, hence there is nothing we can do about it' is not supported by the data contained in the Science article and by the overall epidemiological evidence. Thus, the hypothesis should not be used to diminish the significance of the current efforts in primary cancer prevention.
In the article by Tomasetti and Vogelstein, sex differences are not taken into consideration in the analysis performed and this parameter may weaken the hypothesis that stochastic factors are major determinants in the appearance of tumors belonging to the R group. Except for ovarian and testicular cancer, all the tumors that are used to correlate the total stem cell divisions and lifetime risk do not involve genital tissues and organs. Nevertheless, the incidence of some of the tumors arising from nongenital tissues representing the object of the study is different in males and females. For instance, the incidence of the R-type esophageal cancer in the United States is approximately 5.5/100,000 males, while a frequency of 1.1/100,000 is calculated for females. Similar differences in the sex-specific incidence of esophageal cancer are confirmed in all the other continents, as indicated by the data available for the United Kingdom, Italy, South Africa and Australia (http://globocan.iarc.fr/ia/World/atlas.html). Although data on possible sex-related differences in the number and proliferation potential of esophageal stem cells are not available, it is highly unlikely that males and females are characterized by five-fold differences in this parameter. Remarkable sex-specific variations in the incidence of two other R-tumors, like liver and thyroid cancers, are also well known (http://globocan.iarc.fr/ia/ World/atlas.html). Interestingly, a similar situation applies to kidney cancer although sex-related differences in this tumor are less marked than in the aforementioned types of neoplasia. In fact, a twofold difference in the incidence of kidney cancer is observed throughout the world, as males are significantly more affected by this tumor than females (new cases/100,000 individuals in US: males = 15.9; females = 8.5). At present, the reasons for the sex-dependent differences in the R-type liver, thyroid and esophageal tumors as well as kidney cancer are largely unknown although they may be related to hormonal factors, lifestyle and nutrition habits, which can be modified and represent the target of primary prevention schemes. Indeed, as far as esophageal cancer is concerned, tumor incidence is highly correlated with sex-associated life-style characteristics, such as smoking habits and alcohol drinking, which are easily modifiable factors [4] . On the basis of what is discussed in this section, sex-related differences in the incidence of kidney cancer point to the fact that tumors arising in this organ are unlikely to belong to the R-group.
Another important aspect of tumor epidemiology that is not taken into account by the study and may not be entirely in line with the hypothesis that incidence of Rgroup tumors is primarily due to chance is the geographical variability of this epidemiologic index. The incidence (per 100,000 individuals) of the R-type esophageal cancer in the male population is more than threefold higher in China (18.6) than in the United States (5.5) and Australia (5.4). A high frequency of this tumor is also observed in the southeastern region of Africa, being extremely high in Kenya (20.5). In addition, the incidence of thyroid cancer in the United States, Canada and the United Kingdom is worth noticing, as values of 6.5, 4.8 and 1.5, respectively, are observed in the three countries. This geographical variability hints to genetic predisposition or environmental factors playing a more important role than simple chance in the lifetime risk of esophageal and thyroid cancers. By the same token, it is difficult to reconcile the vast difference in the incidence of the Rtype hepatocellular carcinoma between the US (9.8), Norwegian (2.9) and Swedish (3.4) male populations, with differences in the number and proliferation rate of liver stem cells. Thus, geographical and ethnic differences are other parameters that do not necessarily fit with the idea that chance and stochastic factors associated with stem cell DNA replication are major determinants of R-type tumors. As for kidney cancer, the incidence of this tumor is also subject to geographical differences. For instance, US males (15.9) have an approximately fourfold higher risk than the Brazilian (3.9) counterpart to suffer from kidney cancer. These figures support the importance of the environmental and genetic factors proposed to be associated with an increased risk of kidney cancer such as smoking, regular use of NSAIDs, obesity, faulty genes, a family history of kidney cancer, kidney stones and high blood pressure [5] [6] [7] . Taken together, these factors explain about half of all renal cell cancer cases [8, 9] , while the remainder may be due to unknown factors other than chance. In any case, geographical differences in the incidence represent a second parameter suggesting that kidney cancer is more likely to belong to the D-than to the R-type of tumors.
A further aspect of tumor biology that is not completely consistent with the concept that stochastic events related to DNA replication of cancer stem cells is the heterogeneity of the tumor cell phenotype often observed in tumors originating in the same tissue and presumably from the same stem cell compartment. For instance, both luminal and triple-negative breast cancers should initially derive from the same pluripotent stem cell [10] . Thus, we would expect the same frequency of luminal and triple-negative cancer, if stochastic events linked to DNA replication of normal stem cells were at the basis of both tumor subtypes. Clearly, this is not the case and luminal tumors are 6-7 fold more frequent than the triple negative counterparts. As breast cancer is not included in the study, it is worth mentioning here that glioblastoma, which is classified as an R-type tumor is likely to represent another example of the discussed phenotypic heterogeneity. In fact, at least 10 different subtypes of glioblastoma are known, such as giant cell glioblastoma or pilocytic astrocytoma, and they have different incidences. It would be interesting to know whether the same or different stem cells are basically responsible for the formation the two most common kidney tumors, that is, renal cell carcinoma, which represents over 80% of the neoplastic diseases arising in this organ, and transitional cell carcinoma, which accounts for the majority of the remainder (http:// en.wikipedia.org/wiki/Kidney_cancer). Another example of heterogeneity that challenges the stochastic theory of cancer incidence relates to the intra-organ localization of the tumor. The point is exemplified by gastric cancer, which is not included in the study, and, once again, glioblastoma. For instance, the vast majority of stomach tumors localize to the lesser curvature and only a minority is found in the larger curvature. By the same token, glioblastoma is most often localized to the subcortical white matter of the cerebral hemispheres. Intra-ventricular [11] , cerebellar, spinal glioblastomas [12] and brainstem glioblastomas [13] are infrequent. It is worth mentioning that differences in intra-organ localization of kidney cancers are known, which is again in line with the idea that these tumors are likely to be classified in the D-group.
In the interest of space, we discussed only some of the major points that do not fit with the theory proposed by Tomasetti and Vogelstein, although other general and specific aspects of the study would deserve further discussion. Nevertheless, on the basis of the few points raised, we propose that stem cell divisions and chance are unlikely to be major factors in the genesis of kidney cancer. However, the issue is still open and calls for specific studies, as recent epidemiologic studies indicate that chronic kidney disease, which is purported to be associated with chronic activation of kidney stem cell proliferation, is an important risk factor for renal cancer [14] , with particular reference to papillary renal carcinoma [15] . With respect to this last type of tumor, it is interesting to note that it was recently proposed that papillary renal carcinoma may originate from renal stem cells [16] . At present, one of the main problems in this area is represented by the fact that we still lack basic knowledge on the number, the characteristics and the intra-organ localization of normal kidney stem cells [16] . No matter what is the real role of stem cell division in the genesis of kidney cancer, the theory should not hamper or slowdown studies aimed at determining major and preventable risk factors for this tumor.
We would like to conclude with a general consideration regarding the coverage of the study provided by mass-media, since it represents an example of bad scientific communication. In fact, the oversimplified message conveyed to the layman that the majority of cancer cases cannot be prevented, a statement which is surprisingly present also in the Science Editorial of the Tomasetti and Vogelstein article [2] , cannot be deduced from the original Science article. Indeed, the authors demonstrate that the proportion of cancer risk variation in different tissues can be partially explained by the rate of division of the stem cells in that tissue. Obviously, this does not mean that cancer depends only on 'bad luck', as claimed by the media. In simple terms, it is true that a smoker has a much higher risk than a non-smoker to contract lung cancer. Nevertheless and consistent with a larger lifetime number of stem cell divisions, lung cancer is much more frequent than bone or thyroid cancer even in non-smokers. There is another point that should be considered, as it was en- tirely distorted in the coverage provided by media. Even if chance were indeed an important determinant of the tumor types analyzed by Tomasetti and Vogelstein, which is yet to be unequivocally demonstrated, the concept seems to apply only to relatively infrequent cancer types and certainly not to the majority of oncologic patients, as claimed by the media and by some authoritative commentators. In fact, as already remarked, two of the most frequent tumors, breast and prostate cancer, are not considered by the study. In addition, smoking and certainly not chance is the principal cause of lung cancer, the third most frequent tumor, as discussed earlier and acknowledged by these same authors in the Science article. Thus, from a public health perspective, the claim that the majority of cancer patients should place the blame on 'bad luck' is not only wrong, but it is also dangerous because it is likely to hamper efforts in programs aimed at primary tumor prevention.
